2,667
Views
0
CrossRef citations to date
0
Altmetric
Editorial

SLC2A4 Gene: A Promising Target for Pharmacogenomics of Insulin Resistance

&
Pages 847-850 | Published online: 07 Jun 2013

References

  • Okamoto MM , AnhêGF, Sabino-SilvaR et al. Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver. J. Endocrinol. 211(1) , 55–64 (2011).
  • Machado UF , ShimizuI, SaitoM. Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice. Physiol. Behav.55(4) , 621–625 (1994).
  • Marsh BJ , MartinS, MelvinDR et al. Mutational analysis of the carboxy-terminal phosphorylation site of GLUT-4 in 3T3-L1 adipocytes. Am. J. Physiol. 275(3) , E412–E422 (1998).
  • Zaarour N , BerenguerM, Le Marchand-Brustel Y, Govers R. Deciphering the role of GLUT4 N-glycosylation in adipocyte and muscle cell models. Biochem. J.445(2) , 265–273 (2012).
  • Herman MA , KahnBB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest.116(7) , 1767–1775 (2006).
  • Seraphim PM , NunesMT, MachadoUF. GLUT4 protein expression in obese and lean 12-month-old rats: insights from different types of data analysis. Braz. J. Med. Biol. Res.34(10) , 1353–1362 (2001).
  • Machado UF , ShimizuY, SaitoM. Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose- and monosodium glutamate-treated mice. Horm. Metab. Res.25(9) , 462–465 (1993).
  • de Carvalho Papa P , VargasAM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci.71(16) , 1917–1928 (2002).
  • Zisman A , PeroniOD, AbelED et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6(8) , 924–9928 (2000).
  • Gibbs EM , StockJL, McCoidSC et al. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J. Clin. Invest. 95(4) , 1512–1518 (1995).
  • Bodhini D , RadhaV, GhoshS, MajumderPP, RaoMR, MohanV. GLUT4gene polymorphisms and their association with Type 2 diabetes in south Indians. Diabetes Technol. Ther.13(9) , 913–920 (2011).
  • Kissebah AH , SonnenbergGE, MyklebustJ et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl Acad. Sci. USA 97(26) , 14478–14483 (2000).
  • Choi WH , O‘RahillyS, BuseJB et al. Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects. Diabetes 40(12) , 1712–1718 (1991).
  • Lesage S , ZoualiH, VionnetN et al. Genetic analyses of glucose transporter genes in French non-insulin-dependent diabetic families. Diabetes Metab. 23(2) , 137–142 (1997).
  • Friedel S , AntwerpenB, HochA et al. Glucose transporter 4 gene: association studies pertaining to alleles of two polymorphisms in extremely obese children and adolescents and in normal and underweight controls. Ann. NY Acad. Sci. 967 , 554–557 (2002).
  • Haygood R , FedrigoO, HansonB, YokoyamaKD, WrayGA. Promoter regions of many neural- and nutrition-related genes have experienced positive selection during human evolution. Nat. Genet.39(9) , 1140–1144 (2007).
  • Tarazona-Santos E , FabbriC, YeagerM et al. Diversity in the glucose transporter-4 gene (SLC2A4) in humans reflects the action of natural selection along the old-world primates evolution. PLoS ONE 5(3) , 1–10 (2010).
  • Xia X , HuY, XuL, ChenT. A functional promoter polymorphism of SLC2A4 is associated with aerobic endurance in a Chinese population. Eur. J. Sport Sci.2012 , 1–7 (2012).
  • Xi C , MiyakiK, IkedaS, SongY, SinboT, MuramatsuM. Association of GLUT4 gene variants with HbA1c level in Japanese men. Endocr. J.59(8) , 677–684 (2012).
  • Bj⊘rbaek C , EchwaldSM, HubrichtP et al. Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes 43(8) , 976–983 (1994).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.